Preventive effect of (-)epigallocatechin-gallate (EGCG) on lysosomal enzymes in heart and subcellular fractions in isoproterenol-induced myocardial infarcted Wistar rats

Chemico-Biological Interactions

Volumn 172, Issue 3, 2008, Pages 245-252

  Devika, P T ^a   Prince, P Stanely Mainzen ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Galactosidase; ( )Epigallocatechin gallate; Cathepsin B; Isoproterenol; Myocardial infarction

Indexed keywords

BETA GALACTOSIDASE; BETA GLUCURONIDASE; CATHEPSIN B; CATHEPSIN D; EPIGALLOCATECHIN GALLATE; ISOPRENALINE; N ACETYL BETA GLUCOSAMINIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; HEART INFARCTION; MALE; NONHUMAN; PROPHYLAXIS; RAT;

ANIMALS; CARDIOVASCULAR AGENTS; CATECHIN; DISEASE MODELS, ANIMAL; HEART; ISOPROTERENOL; LYSOSOMES; MALE; MYOCARDIAL INFARCTION; RATS; RATS, WISTAR; SUBCELLULAR FRACTIONS; TIME FACTORS;

RATTUS; RATTUS NORVEGICUS;

EID: 40949114175     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.01.003     Document Type: Article

References (50)

1. De Bono D.P., and Boon N.A. Disease of the cardiovascular system. In: Edwards C.R.W., and Bouchier I.A.S. (Eds). Davidson's Principles of Practice and Medicine (1992), Churchill Livingstone, Hong Kong 249-340
2. Rona G. Catecholamine cardiotoxicity. J. Mol. Cell. Cardiol. 17 (1985) 291-306
3. Milei J., Nunez R.G., and Rapaport M. Pathogenesis of isoproterenol induced myocardial lesions its relation to human coagulate myocytolysis. Cardiology 63 (1978) 139-151
4. Thompson J.A., and Hess M.L. The oxygen free radical system: a fundamental mechanism in the production of myocardial necrosis. Prog. Cardiovasc. Dis. 28 (1986) 449-462
5. Nirmala C., and Puvanakrishnan R. Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Mol. Cell. Biochem. 159 (1996) 85-93
6. Rice-Evans C.A., Miller N.J., and Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 20 (1996) 933-956
7. Bettuzzi S., Brausi M., Rizzi F., Castagnetti G., Peracchia G., and Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 66 (2006) 1234-1240
8. Dale-Nagle G., Ferreira D., and Zhou Y.D. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry 67 (2006) 1849-1855
9. Vita J.A. Tea consumption and cardiovascular disease: effects on endothelial function. J. Nutr. 133 (2003) 3293S-3297S
10. Hertog M.G., Feskens E.J.M., Hollman P.C.H., Martijn B., and Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet 342 (1993) 1007-1011
11. Koh S.H., Kim S.H., Kwon H., Park Y., Kim K.S., Song C.W., Kim J., Kim M.H., Yu H.J., Henkel J.S., and Jung H.K. Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical stress induced apoptosis through its effect on phosphoinositide 3-kinase/AKt and glycogen synthase kinase-3. Brain Res. Mol. Brain Res. 118 (2003) 72-81
12. Mochizuki M., and Hasegawa N. Protective effect of (-)-epigallocatechin gallate on acute experimental colitis. J. Health Sci. 51 (2005) 362-364
13. Arts I.C., Hollman P.C., Feskens E.J., Bueno de mesquita H.B., and Kromhout D. Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen elderly study. Am. J. Clin. Nutr. 70 (2001) 227-232
14. Tipoe G.L., Leung M.W., Hung M., and Fung M.L. Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. Cardiovasc. Hematol. Disord. Drug Targets 7 (2007) 135-144
15. Maliakal P.P., Coville P.F., and Wanwimolruk S. Tea consumption modulates hepatic drug metabolizing enzymes in wistar rats. J. Pharm. Pharmacol. 53 (2001) 569-577
16. Persson I.A., Josefesson M., Persson K., and Andersson R.G. Tea flavonols inhibit angiotensin-converting enzyme activity and increase nitric oxide production in human endothelial cells. J. Pharm. Pharmacol. 58 (2006) 1139-1144
17. Ravichandran L.V., Puvanakrishanan R., and Joseph K.T. Alterations in the heart lysosomal stability in isoproterenol induced myocardial infarction in rats. Biochem. Int. 22 (1990) 387-396
18. Todd G.L., Cullan G.E., and Cullan G.M. Isoproterenol induced myocardial necrosis and membrane permeability alteration in the isolated perfused rabbit heart. Exp. Mol. Pathol. 33 (1980) 43-54
19. P.T. Devika, P.Stanely Mainzen Prince, (-)Epigallocatechin-gallate (EGCG) prevents isoproterenol induced cardiac toxicity by stabilizing cardiac marker enzymes and membrane bound-ATPases, J. Pharm. Pharmacol., in press.
20. P.T. Devika, P. Stanely Mainzen Prince, Protective effect of (-)epigallocatechin-gallate (EGCG) on lipid peroxide metabolism in isoproterenol induced myocardial infarction in male wistar rats: a histopathological study, Biomed. Pharmacother., in press.
21. Sathish V., Ebenezar K.K., and Devaki T. Synergistic effect of nicorandil and amlodipine on lysosomal hydrolases during experimental myocardial infarction in rats. Biomed. Pharmacother. 57 (2003) 309-313
22. Kawai Y., and Anno K. Mucopolysaccharide-degrading enzymes from the liver of the squid, Ommastrephes sloani pacificus. 1. Hyaluronidase Biochem. Biophys. Acta 242 (1971) 428-436
23. Moore J.C., and Morris J.E. A simple automated colorimetric method for determination of N-acetyl-β-d-glucosaminidase. Ann. Clin. Biochem. 19 (1982) 157-159
24. Conchie J., Gelman A.L., and Levy G.A. Inhibition of glycosidases by aldonolactones of corresponding configuration. The C-4 and C-6 specificity of β-glucosidase and β-galactosidase. Biochem. J. 103 (1967) 609-615
25. Sapolsky A.L., Altman R.D., and Howell D.S. Cathepsin-D activity in normal and osteoarthritic human cartilage. Fed. Proc. 32 (1973) 1489-1493
26. Barrett A.J. New assay for cathepsin B1 and other thiol proteinase. Anal. Biochem. 47 (1972) 280-293
27. Lowry O.H., Rosebrough M.J., Farr A.L., and Randall R.J. Protein measurement with folin-phenol reagent. J. Biol. Chem. 193 (1951) 265-275
28. Kukreja R.C., and Hess M.L. The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc. Res. 26 (1992) 641-655
29. Kuzuya T., Fuji H., Hoshida S., Kitabatake A., and Tada M. Neutrophil-induced myocardial cell damage and active oxygen metabolities. Jpn. Circ. J. 55 (1991) 1127-1131
30. Burton K.P., Morris A.C., Massey K.D., Buja L.M., and Hagler H.K. Free radicals alter ionic calcium levels and membrane phospholipids in cultured rat ventricular myocytes. J. Mol. Cell Cardiol. 22 (1990) 1035-1047
31. Riccutti M.A. Myocardial lysosome stability in the early stages of acute ischemic injury. Am. J. Cardiol. 30 (1992) 492-497
32. Decker R.S., and Wildenthal K. Sequential lysosomal alterations during cardiac ischemia. II. Ultrastructural and cytochemical changes. Lab. Invest. 38 (1978) 662-673
33. Niebes P., and Ponard G. Stabilization of rat liver lysosomes by (+)-cyanidanol-3 in vivo. Biochem. Pharmacol. 24 (1975) 905-909
34. Macickova T., Navarova J., Urbancikova M., and Horakova K. Comparison of isoproterenol induced changes in lysosomal enzyme activity in vivo and in vitro. Gen. Physiol. Biophys. 18 (1999) 86-91
35. Mayanskaya S.D., Mayanskaya N.N., Efremov A.V., and Yakobson G.S. Activity of lysosomal apparatus in rat myocardium during experimental coronary and noncoronary myocardial damage. Bull. Exp. Biol. Med. 129 (2000) 530-532
36. Kennett F.F., and Weglicki W.B. Effect of well-defined ischemia on myocardial lysosomal and microsomal enzymes in a canine model. Circ. Res. 43 (1978) 750-758
37. Sano M., Takahashi Y., Yoshino K., Shimoi K., Nakamura Y., Tomita I., Oquni I., and Konomoto H. Effect of tea (Camellia sinensis L.) on lipid peroxidation in rat liver and kidney: a comparison of green and black tea feeding. Biol. Pharm. Bull. 18 (1995) 1006-1008
38. Guo Q., Zhao B., Li M., Shen S., and Xin W. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochem. Biophys. Acta 1304 (1996) 210-222
39. Ravens K.G., and Gudbjarnason S. Changes in the activities of lysosomal enzymes in infarcted canine heart muscle. Circ. Res. 24 (1969) 851-857
40. Brunk U.T., Neuzil J., and Eaton J.W. Lysosomal involvement of apoptosis. Redox. Rep. 6 (2001) 91-97
41. Townsend P.A., Scarabelli T.M., Pasini E., Gitti G., Menegazzi M., Suzuki H., Knight R.A., Latchman D.S., and Stephanou A. Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis. FASEB J. 18 (2004) 1621-1623
42. Aneja R., Hake P.W., Burroughs T.J., Denenberg A.G., Wong H.R., and Zingarelli B. Epigallocatechin, a green tea polyphenol attenuates myocardial ischemia reperfusion injury in rats. Mol. Med. 10 (2004) 55-62
43. Ullmann U., Haller J., Decourt J.P., Girault N., Girault J., Richard Caudron A.S., Pineau B., and Weber P. A single ascending dose study of epigallocatechin gallate in healthy volunteers. J. Int. Med. Res. 31 (2003) 88-101
44. Meng X., Sang S., Zhu N., Lu H., Sheng S., Lee M.J., Ho C.T., and Yang C.S. Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice and rats. Chem. Res. Toxicol. 15 (2002) 1042-1050
45. Lee M.J., Maliakal P., Chen L., Meng X., Bondoc F.Y., Prabhu S., Lambert G., Mohr S., and Yang C.S. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans; formation of different metabolites and individual variability. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 1025-1032
46. Chow H.H.S., Cai Y., Alberts D.S., Hakim I., Dorr R., Shahi F., Crowell J.A., Yang C.S., and Hara Y. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 53-58
47. Lee M.J., Wang Z.Y., Li H., Chen L., Sun Y., Gobbo S., Balentine D.A., and Yang C.S. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol. Biomarkers Prev. 4 (1995) 393-399
48. Yang C.S., Chen L., Lee M.J., Balentine D., Kuo M.C., and Schantz S.P. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomarkers Prev. 7 (1998) 351-354
49. Mukai K., Mitani S., Ohara K., and Nagaoka S. Structure-activity relationship of the tocopherol-regeneration reaction by catechins. Free Radic. Biol. Med. 38 (2005) 1243-1253
50. Niki E., Saito T., Kawakami A., and Kamiya Y. Inhibition of oxidation of methyl linoleate in solution by vitamin E and vitamin C. J. Biol. Chem. 259 (1984) 4177-4182